Cargando…
Magnetic Resonance Spectroscopy in ALS
Proton magnetic resonance spectroscopy (MRS) provides a means of measuring cerebral metabolites relevant to neurodegeneration in vivo. In amyotrophic lateral sclerosis (ALS), neurochemical changes reflecting neuronal loss or dysfunction (decreased N-actylaspartate [NAA]) is most significant in the m...
Autor principal: | Kalra, Sanjay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524558/ https://www.ncbi.nlm.nih.gov/pubmed/31133975 http://dx.doi.org/10.3389/fneur.2019.00482 |
Ejemplares similares
-
(1)H Magnetic Resonance Spectroscopy to Understand the Biological Basis of ALS, Diagnose Patients Earlier, and Monitor Disease Progression
por: Caldwell, Sarah, et al.
Publicado: (2021) -
Magnetic Resonance Spectroscopy and Bipolar Disorder: How Feasible Is This Pairing?
por: Sosa-Moscoso, Bernardo, et al.
Publicado: (2022) -
Longitudinal Changes in Magnetic Resonance Spectroscopy in Pediatric Concussion: A Pilot Study
por: Meyer, Erin J., et al.
Publicado: (2019) -
Proton Magnetic Resonance Spectroscopy for Diagnosis of Non-Motor Symptoms in Parkinson's Disease
por: Guan, Ji-tian, et al.
Publicado: (2022) -
Magnetic resonance spectroscopy investigation in the right human hippocampus following spinal cord injury
por: Pfyffer, Dario, et al.
Publicado: (2023)